IL17A and psoriasis: The particular pathogenicity of TRM CD8 + in psoriasis is evidenced by the fact that they express the receptor for IL-23 and can produce pro-inflammatory IL-17 and IL-22 in the skin, even many months after the lesion has resolved [4,13].